CLINICAL AND HISTOLOGICAL COMPLETE REMISSION OF AN ADVANCED CUTANEOUS SQUAMOUS-CELL CARCINOMA UNDER CHEMOTHERAPY ONLY

被引:0
|
作者
EVENOU, P
CVITKOVIC, E
MAMELLE, G
DUVILLARD, P
KLIJANIENKO, G
WAGNER, L
NOBLE, JP
WENDLING, JL
GUILLAUME, JC
AVRIL, MF
机构
[1] INST GUSTAVE ROUSSY,39 RUE CAMILLE DESMOULINS,F-94805 VILLEJUIF,FRANCE
[2] GRP HOSP PITIE SALPETRIERE,F-75651 PARIS 13,FRANCE
来源
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:1285 / 1288
页数:4
相关论文
共 50 条
  • [21] CHEMOTHERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE OROPHARYNX
    ARNHOLDSCHNEIDER, M
    POLYZOIDIS, T
    HNO, 1987, 35 (11) : 468 - 471
  • [22] CHEMOTHERAPY OF SQUAMOUS-CELL CARCINOMA OF THE CERVIX
    LLORENS, AS
    OBSTETRICS AND GYNECOLOGY, 1980, 55 (03): : 373 - 375
  • [23] CHEMOTHERAPY FOR ADVANCED ADENOCARCINOMA AND SQUAMOUS-CELL CARCINOMA OF THE LUNG WITH ETOPOSIDE AND CISPLATIN
    DHINGRA, HM
    VALDIVIESO, M
    BOOSER, DJ
    UMSAWASDI, T
    CARR, DT
    CHIUTEN, DF
    MURPHY, WK
    ISSELL, BF
    SPITZER, G
    FARHA, P
    DIXON, C
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 671 - 673
  • [24] SEQUENTIAL COMBINATION CHEMOTHERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    LESTER, EP
    KINNEALEY, A
    MATZ, GJ
    LARYNGOSCOPE, 1979, 89 (12): : 1921 - 1929
  • [25] TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA
    KEARSLEY, JH
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1989, 19 (06): : 745 - 746
  • [26] ADVANCED SQUAMOUS-CELL CARCINOMA OF THE LARYNX
    LINDELOV, B
    HANSEN, HS
    ACTA ONCOLOGICA, 1990, 29 (04) : 505 - 508
  • [27] Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
    Chen, Alessandra
    Ali, Nabilah
    Boasberg, Peter
    Ho, Allen S.
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (01)
  • [28] Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma
    Ramadan, Khaled M. A.
    McKenna, Kevin E.
    Morris, Treen C. M.
    LANCET ONCOLOGY, 2006, 7 (11): : 958 - 959
  • [29] Complete Remission of ossar metastatic Squamous Cell Carcinoma under Pembrolizumab
    Pietschke, K.
    Lomberg, D.
    Koechel, A.
    Mueller, A.
    Eigentler, T.
    Leiter-Stoeppke, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 73 - 73
  • [30] PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
    Migden, M. R.
    Rischin, D.
    Schmults, C. D.
    Guminski, A.
    Hauschild, A.
    Lewis, K. D.
    Chung, C. H.
    Hernandez-Aya, L.
    Lim, A. M.
    Chang, A. L. S.
    Rabinowits, G.
    Thai, A. A.
    Dunn, L. A.
    Hughes, B. G. M.
    Khushalani, N. I.
    Modi, B.
    Schadendorf, D.
    Gao, B.
    Seebach, F.
    Li, S.
    Li, J.
    Mathias, M.
    Booth, J.
    Mohan, K.
    Stankevich, E.
    Babiker, H. M.
    Brana, I.
    Gil-Martin, M.
    Homsi, J.
    Johnson, M. L.
    Moreno, V.
    Niu, J.
    Owonikoko, T. K.
    Papadopoulos, K. P.
    Yancopoulos, G. D.
    Lowy, I.
    Fury, M. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 341 - 351